Cell detachment ratio on pH-responsive chitosan : A useful biometric for prognostic judgment and drug efficacy assessment in oncology

Copyright © 2021 Elsevier Ltd. All rights reserved..

The inherently unpredictable complexity of tumors impedes the widespread practice of the molecular biomarkers in outcome prediction. Alternatively, from the biophysical perspective, this study sought to investigate the applicability of the cell detachment ratio (CDR) derived from pH-responsive chitosan as a biometrical identifier for the disease state in cancer prognostic judgment and drug efficacy assessment. In the targeted therapy model, the repression of tumor dissemination in cells harboring aberrant ErbB signals (human non-small cell lung cancer cell line PC9 and breast cancer cell line BT474) were first demonstrated both in vitro and in vivo. Consequently, the corresponding CDR profile goes synchronously with the extent of cancer regression in response to the medication. Definitive integrins that drive the cell detachment were also verified through CDR examination following the integrin functional blockade. Conclusively, CDR is a promising clinical index for evaluation of the metastatic cell behaviors in terms of the cell detachment.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:261

Enthalten in:

Carbohydrate polymers - 261(2021) vom: 01. Juni, Seite 117911

Sprache:

Englisch

Beteiligte Personen:

Yen, Chia-Hsiang [VerfasserIn]
Young, Tai-Horng [VerfasserIn]
Huang, Tsung-Wei [VerfasserIn]

Links:

Volltext

Themen:

9012-76-4
Antineoplastic Agents
Cell adhesive strength
Cell detachment ratio
Chitosan
Drug efficacy
Integrin
Journal Article
PH-responsive chitosan
Prognosis judgment

Anmerkungen:

Date Completed 03.05.2021

Date Revised 03.05.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.carbpol.2021.117911

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM323223362